The first 12 weeks of titration - what it actually feels like

The word titration can make starting ADHD medication sound like a pharmacology experiment. In practice it is simpler than that. We start you on a low dose, we see how you respond over a week or two, we adjust if needed, and we repeat until the dose is doing what it should without causing you problems. Most people reach a settled dose by week eight to twelve.

This article walks through what that actually feels like, week by week, so you know what is normal and when to get in touch.

Why we titrate in the first place

ADHD medications are dose-dependent. Too low a dose does very little. Too high a dose produces unnecessary side effects. The dose that is right for you depends on your body weight, your metabolism, how sensitive your system is to stimulants, whether you also take other medications, and what you want the medication to do for you. There is no way to predict the perfect dose in advance, so we find it by stepping up carefully.

For lisdexamfetamine (Elvanse), typical adult starting doses are 30mg once daily, stepping up in 20mg increments every one to two weeks to a usual effective dose between 40mg and 70mg. For methylphenidate, the range is wider but the same principle applies.

Weeks 1-2: Starting dose

You take your first tablet on day one, usually in the morning. Most patients notice the effect within an hour. Lisdexamfetamine tends to come on gently over an hour to ninety minutes and stays smooth through the day. Immediate-release methylphenidate peaks and wears off faster; modified-release methylphenidate sits in between.

The feeling most people describe on a well-matched dose is "quiet". The mental chatter drops. You can sit with a task long enough to finish it. You notice you have stopped interrupting people mid-sentence. Often the biggest change is not what you can do but what you are no longer fighting to do.

Common side effects in the first two weeks include reduced appetite, slight dry mouth, a mild increase in heart rate, and occasionally feeling more alert in the evening than you want to be. Most of these settle by week two or three. If they do not, we adjust the dose or the timing.

Less common but important: if you feel unusually anxious, your heart is racing at rest, you are getting headaches that are not settling, or your sleep has completely collapsed, message us. We will adjust the dose or the drug. This is the point of the titration period.

Weeks 2-4: First review and dose adjustment

Two weeks in, your GP reviews your progress. The questions we ask:

Is the medication helping? If yes, how much and in what ways?

Are you experiencing any side effects? How significant?

How is your sleep, appetite, and mood?

What time of day does the effect wear off? Is that where you want it?

Based on your answers, we either keep the dose the same, step it up, step it down, or switch medications. If you are responding partially but the effect is not lasting long enough into the afternoon, we typically step up. If you are responding but with side effects, we sometimes hold or step down.

Weeks 4-8: Fine-tuning

By this point most patients are on their second or third dose level. You start to get a feel for what your medication can and cannot do. It is not a personality transplant. It will not make tasks you dislike magically interesting. What it does do is remove the executive-function fog that used to sit between wanting to do something and actually starting it.

Common things patients notice in this window:

You underestimate how much you are getting done because the old effort-for-nothing feedback loop has been so familiar for so long.

Your eating pattern has reorganised. Most patients lose appetite during the day and eat more in the evening. We help you keep this nutritionally sensible with a simple strategy: do not skip breakfast, plan a proper meal in the early evening.

Your sleep is variable. Some patients sleep better because the mental chatter that used to keep them awake has quieted. Others find they have to be more disciplined about when they take the dose, particularly if they are on a modified-release formulation.

Weeks 8-12: Settling on a stable dose

Around week eight to twelve, most patients have a settled dose that works for them. You are no longer chasing the next dose adjustment; you are just taking your medication and getting on with your life.

At this point we do a stable-dose review. The purpose of this review is different from the titration reviews. We check that the effect is holding steady, that you are not developing tolerance, that any initial side effects have fully settled, and that your physical parameters (blood pressure, heart rate, weight) are in a normal range. We repeat this stable-dose review every six months thereafter.

When things are not going well

Most patients settle within twelve weeks. Some take longer. A few never find a stimulant that suits them, and we switch to a non-stimulant (atomoxetine or guanfacine), which has a slower onset but can work well.

Reasons to message us between scheduled reviews:

Persistent side effects that are not improving.

Resting heart rate consistently above 100 or blood pressure consistently elevated.

Mood changes, particularly low mood, agitation, or intrusive thoughts.

Concerns about how you are responding that you would like us to address before your next review.

You have unlimited messaging access to your clinician as part of your ongoing care subscription. Use it. We would rather hear about a small concern early than a big one late.

The honest summary

The first twelve weeks are a process. Most people feel meaningful benefit within the first week and settle on a stable dose within three months. The experience is more boring than people expect, which is exactly what it should be.

Ready to start?

If this article has made you think it is time to find out, the next step is a short consultation with one of our ADHD-trained GPs.

Begin your consultation at this link. Online in 30 minutes, or in person at Westfield London.